R) IVUS Technology Used In Imaging Study Of GlaxoSmithKline's Novel...
Volcano's VHMedical News Today: 3 views since Wednesday, September 3, 2008 at 06:13 AM
Volcano Corporation (Nasdaq: VOLC) [ESC Booth # A2-D403], a leading manufacturer of intravascular ultrasound (IVUS) and functional measurement (FM) technology, announced the use of its VH(R) IVUS (Virtual Histology IVUS) in GlaxoSmithKline's IBIS-2 trial (Integrated Biomarker and Imaging Study).

Published in: Procedures and Therapies